DEFA14A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

 

  Filed by the registrant                      Filed by a party other than the registrant

 

 

Check the appropriate box:

 

   

 

               

 

 

 

Preliminary Proxy Statement

 

   

 

    

 

 

 

CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (AS PERMITTED BY RULE 14A-6(E)(2))

 

   

 

    

 

 

 

Definitive Proxy Statement

 

   

 

    

 

 

 

Definitive Additional Materials

 

   

 

    

 

 

 

Soliciting Material Pursuant to Section 240.14a-12

 

AMGEN INC.

(Name of Registrant as Specified in Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

 

 

Payment of filing fee (check the appropriate box):

 

 

               

 

 

 

No fee required.

 

 

    

 

 

 

Fee paid previously with preliminary materials.

 

 

    

 

 

Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

 


SAMPLE

 

LOGO

Your Vote Counts! AMGEN INC. 2022 Annual Meeting Vote by May 16, 2022 11:59 PM ET for shares held directly. For shares held in plans sponsored by Amgen or its subsidiaries, vote by May 12, 2022 11:59 PM ET. AMGEN INC. ONE AMGEN CENTER DRIVE THOUSAND OAKS, CA 91320-1799 ATTN: CORPORATE SECRETARY D72148-P66388 You invested in AMGEN INC. and it’s time to vote! You have the right to vote on items, including the election of directors, being presented at the Annual Meeting. This is an important notice regarding the availability of proxy material for the stockholder meeting to be held on May 17, 2022. Get informed before you vote View the Notice of 2022 Annual Meeting of Stockholders, Proxy Statement, Form Proxy Card and 2021 Annual Report online OR you can receive a free paper or email copy of the material(s) by making such request prior to May 3, 2022. If you would like to request a copy of the material(s) for this and/or future stockholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy. For complete information and to vote, visit www.ProxyVote.com Control # Vote Virtually at the Meeting May 17, 2022 11:00 A.M., Pacific Time For holders as of: March 18, 2022 Smartphone users Point your camera here and vote without entering a control number Virtually at: www.virtualshareholdermeeting.com/AMGN2022 The Amgen Inc. 2022 Annual Meeting of Stockholders will be held solely by remote communication via the Internet. While you will not be able to attend the Annual Meeting in person, stockholders will, to the extent possible, be afforded the same rights and opportunities to participate at the virtual meeting similarly to how they would participate at an in-person meeting. V1.1


SAMPLE

 

LOGO

Vote at www.ProxyVote.com THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming stockholder meeting. Please follow the instructions on the reverse side to vote these important matters. Board Recommends Voting Items 1. To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2023 Annual Meeting of Stockholders. The nominees for election to the Board of Directors are: 1a. Dr. Wanda M. Austin For 1b. Mr. Robert A. Bradway For 1c. Dr. Brian J. Druker For 1d. Mr. Robert A. Eckert For 1e. Mr. Greg C. Garland For 1f. Mr. Charles M. Holley, Jr. For 1g. Dr. S. Omar Ishrak For 1h. Dr. Tyler Jacks For 1i. Ms. Ellen J. Kullman For 1j. Ms. Amy E. Miles For 1k. Dr. Ronald D. Sugar For 1l. Dr. R. Sanders Williams For 2. Advisory vote to approve our executive compensation. For 3. To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2022. For NOTE: Such other business as may properly come before the meeting or any continuation, postponement, or adjournment thereof. Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Sign up for E-delivery”. D72149-P66388